Dr Paul Kemp (Chairman)

Paul Kemp has been heavily involved in commercial Tissue Engineering for the last 17 years both in the U.S. and the U.K. After post-doctoral research on the biochemistry of collagen cross-links at Manchester University, he joined Organogenesis Inc in late 1986. Boston based Organogenesis is the world’s first Tissue Engineering company and while there Paul was instrumental in the commercial development of Apligraf which was to become the FDA’s first approved manufactured human organ and is currently used in the U.S. for the treatment of chronic wounds. During his time at Organogenesis, Paul was heavily involved in all aspects of the pioneering of this new area of medicine and taking on several different roles eventually becoming a Vice President.

Paul left Organogenesis in 1997 to return to the UK and founded Intercytex in 1999. This company is devoted to the cellular induction of human tissues and organs and has four products in hair and skin regeneration that are undergoing clinical studies. The company has facilities in Cambridge, UK and Boston, MA and its main GMP manufacturing facility and laboratories in Manchester, UK. Intercytex floated on AIM in 2006 and has so far raised over £42m in public and private funds. Paul has published on Tissue Engineering and holds several patents relating to tissue engineered tissues and organs.

Back to Our People